Effectiveness and safety of oral dutasteride for male androgenetic alopecia in real clinical practice: A descriptive monocentric study-Reference-Cited by-同舟云学术

Effectiveness and safety of oral dutasteride for male androgenetic alopecia in real clinical practice: A descriptive monocentric study

Published:2019-12-18 Issue:1 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Vañó‐Galván Sergio¹^ORCID,Saceda‐Corralo David¹,Moreno‐Arrones Oscar M.¹,Rodrigues‐Barata Rita¹²,Morales Carlos¹²,Gil‐Redondo Rocío¹²,Bernárdez‐Guerra Claudia¹²,Hermosa‐Gelbard Ángela¹²,Jaén‐Olasolo Pedro¹²

Affiliation:

1. Trichology UnitRamon y Cajal University Hospital, IRYCIS, University of Alcala Madrid Spain

2. Trichology and Hair Transplantation UnitGrupo Pedro Jaen Clinic Madrid Spain

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.13182

Reference6 articles.

1. Long-term efficacy and safety of the dual 5-alpha reductase blocker dutasteride on male androgenetic alopecia patients

2. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia

3. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version

4. The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride

5. Estudio transversal acerca de los hábitos de prescripción en alopecia androgénica de los dermatólogos en España en 2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Supplementation with <sc>l</sc>-Cystine, Serenoa repens, Cucurbita pepo, and Pygeum africanum in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study;Skin Appendage Disorders;2024-07-26

2. Impact of Finasteride and Dutasteride in Beard Thickness in Men With Androgenetic Alopecia: A 453-patient Retrospective Trial;Actas Dermo-Sifiliográficas;2024-07

3. Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies;Journal of Clinical Medicine;2024-05-23

4. Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia;Expert Opinion on Emerging Drugs;2024-04-26

5. What’s New in Therapy for Male Androgenetic Alopecia?;American Journal of Clinical Dermatology;2022-09-28